Table of Contents 
ISRN Pediatrics
Volume 2011 (2011), Article ID 707206, 9 pages
http://dx.doi.org/10.5402/2011/707206
Research Article

High-Sensitivity C Reactive Protein: Associations with Cardiovascular Risk Factors and Tracking in Female Adolescents and Young Adults

John A. Morrison,1 Charles J. Glueck,2 Stephen R. Daniels,3 Ping Wang,2 Davis M. Stroop,4 and Paul S. Horn5,6

1Division of Cardiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229-3039, USA
2Cholesterol Center, Jewish Hospital of Cincinnati-Mercy Health Partners, ABC Building, 3200 Burnet Avenue, Cincinnati, OH 45229, USA
3Children's Hospital, Denver, CO 80045, USA
4Division of Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229-3039, USA
5Department of Mathematical Sciences, University of Cincinnati, Cincinnati, OH 45221, USA
6Psychiatry Service, Veterans Affairs Medical Center, Cincinnati, OH 45220, USA

Received 24 November 2010; Accepted 30 December 2010

Academic Editors: C. D. Berkowitz and S. A. Sarker

Copyright © 2011 John A. Morrison et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. S. Berenson and S. R. Srinivasan, “Emergence of obesity and cardiovascular risk for coronary artery disease: the Bogalusa Heart Study,” Preventive Cardiology, vol. 4, no. 3, pp. 116–121, 2001. View at Google Scholar · View at Scopus
  2. M. D. Haust, “The genesis of atherosclerosis in pediatric age-group,” Pediatric Pathology, vol. 10, no. 1-2, pp. 253–271, 1990. View at Google Scholar · View at Scopus
  3. H. C. McGill Jr., C. A. McMahan, E. E. Herderick, G. T. Malcom, R. E. Tracy, and J. P. Strong, “Origin of atherosclerosis in childhood and adolescence,” American Journal of Clinical Nutrition, vol. 72, no. 5, pp. 1307S–1315S, 2000. View at Google Scholar · View at Scopus
  4. C. A. McMahan, S. S. Gidding, Z. A. Fayad et al., “Risk scores predict atherosclerotic lesions in young people,” Archives of Internal Medicine, vol. 165, no. 8, pp. 883–890, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. C. A. McMahan, S. S. Gidding, G. T. Malcom, R. E. Tracy, J. P. Strong, and H. C. McGill Jr., “Pathobiological determinants of atherosclerosis in youth risk scores are associated with early and advanced atherosclerosis,” Pediatrics, vol. 118, no. 4, pp. 1447–1455, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. L. H. Kuller, “Cardiovascular disease is preventable among women,” Expert Review of Cardiovascular Therapy, vol. 8, no. 2, pp. 175–187, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Stamler, J. D. Neaton, and D. N. Wentworth, “Blood pressure (systolic and diastolic) and risk of fatal coronary heart disease,” Hypertension, vol. 13, no. 5, pp. 2–12, 1989. View at Google Scholar · View at Scopus
  8. S. Lamon-Fava, P. W. F. Wilson, and E. J. Schaefer, “Impact of body mass index on coronary heart disease risk factors in men and women: the Framingham Offspring Study,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 16, no. 12, pp. 1509–1515, 1996. View at Google Scholar · View at Scopus
  9. M. Wei, B. D. Mitchell, S. M. Haffner, and M. P. Stern, “Effects of cigarette smoking, diabetes, high cholesterol, and hypertension on all-cause mortality and cardiovascular disease mortality in Mexican Americans: the San Antonio Heart Study,” American Journal of Epidemiology, vol. 144, no. 11, pp. 1058–1065, 1996. View at Google Scholar · View at Scopus
  10. P. M. Ridker, E. Danielson, F. A. Fonseca et al., “Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial,” The Lancet, vol. 373, no. 9670, pp. 1175–1182, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. P. M. Ridker, C. H. Hennekens, J. E. Buring, and N. Rifai, “C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women,” New England Journal of Medicine, vol. 342, no. 12, pp. 836–843, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. P. M. Ridker, M. Cushman, M. J. Stampfer, R. P. Tracy, and C. H. Hennekens, “Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men,” New England Journal of Medicine, vol. 336, no. 14, pp. 973–979, 1997. View at Publisher · View at Google Scholar · View at Scopus
  13. L. H. Kuller, R. P. Tracy, J. Shaten, and E. N. Meilahn, “Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study,” American Journal of Epidemiology, vol. 144, no. 6, pp. 537–547, 1996. View at Google Scholar
  14. W. Koenig, M. Sund, M. Fröhlich et al., “C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the MONICA (monitoring trends and determinants in cardiovascular disease) Augsburg cohort study, 1984 to 1992,” Circulation, vol. 99, no. 2, pp. 237–242, 1999. View at Google Scholar · View at Scopus
  15. J. Danesh, P. Whincup, M. Walker et al., “Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses,” British Medical Journal, vol. 321, no. 7255, pp. 199–204, 2000. View at Google Scholar · View at Scopus
  16. J. Spranger, A. Kroke, M. Möhlig et al., “Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study,” Diabetes, vol. 52, no. 3, pp. 812–817, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. N. Mauras, C. DelGiorno, C. Kollman et al., “Obesity without established comorbidities of the metabolic syndrome is associated with a proinflammatory and prothrombotic state, even before the onset of puberty in children,” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 3, pp. 1060–1068, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. S. P. Yang, C. X. Gong, B. Y. Cao, and C. Yan, “Relationship between serum high-sensitivity C-reactive protein and obesity and impaired glycose metabolism in children and adolescents,” Zhonghua Er Ke Za Zhi, vol. 44, no. 12, pp. 933–936, 2006. View at Google Scholar · View at Scopus
  19. O. Guran, F. Akalin, C. Ayabakan, F. Y. Dereli, and G. Haklar, “High-sensitivity C-reactive protein in children at risk for coronary artery disease,” Acta Paediatrica, International Journal of Paediatrics, vol. 96, no. 8, pp. 1214–1219, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Soriano-Guillén, B. Hernández-García, J. Pita, N. Domínguez-Garrido, G. Del Río-Camacho, and A. Rovira, “High-sensitivity C-reactive protein is a good marker of cardiovascular risk in obese children and adolescents,” European Journal of Endocrinology, vol. 159, no. 1, pp. R1–R4, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Juonala, J. S. A. Viikari, T. Rönnemaa, L. Taittonen, J. Marniemi, and O. T. Raitakari, “Childhood C-reactive protein in predicting CRP and carotid intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 8, pp. 1883–1888, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. M. J. Järvisalo, A. Harmoinen, M. Hakanen et al., “Elevated serum C-reactive protein levels and early arterial changes in healthy children,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 22, no. 8, pp. 1323–1328, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. A. W. Zieske, R. P. Tracy, C. A. McMahan et al., “Elevated serum C-reactive protein levels and advanced atherosclerosis in youth,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 6, pp. 1237–1243, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. J. A. Morrison, “Obesity and cardiovascular disease risk factors in Black and White girls: the NHLBI Growth and Health Study,” American Journal of Public Health, vol. 82, no. 12, pp. 1613–1620, 1992. View at Google Scholar · View at Scopus
  25. J. A. Morrison, C. J. Glueck, P. S. Horn, G. B. Schreiber, and P. Wang, “Pre-teen insulin resistance predicts weight gain, impaired fasting glucose, and type 2 diabetes at age 18-19 y: a 10-y prospective study of black and white girls,” American Journal of Clinical Nutrition, vol. 88, no. 3, pp. 778–788, 2008. View at Google Scholar · View at Scopus
  26. E. A. Lawson, K. K. Miller, V. A. Mathur et al., “Hormonal and nutritional effects on cardiovascular risk markers in young women,” Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 8, pp. 3089–3094, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. S. E. Barlow and W. H. Dietz, “Obesity evaluation and treatment: expert Committee recommendations. The Maternal and Child Health Bureau, Health Resources and Services Administration and the Department of Health and Human Services,” Pediatrics, vol. 102, no. 3, p. E29, 1998. View at Google Scholar · View at Scopus
  28. T. Cole, “Weight-stature indices to measure underweight, overweight, and obesity,” in Anthropometric Assessment of Nutritional Status, J. H. Hines, Ed., pp. 83–111, Wiley-Liss, New York, NY, USA, 1991. View at Google Scholar
  29. R. J. Kuczmarski, C. L. Ogden, S. S. Guo et al., “2000 CDC Growth Charts for the United States: methods and development,” Vital and Health Statistics. Series 11, no. 246, pp. 1–190, 2002. View at Google Scholar · View at Scopus
  30. V. De Leo, M. C. Musacchio, G. Morgante, P. Piomboni, and F. Petraglia, “Metformin treatment is effective in obese teenage girls with PCOS,” Human Reproduction, vol. 21, no. 9, pp. 2252–2256, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. K. G. M. M. Alberti and P. Z. Zimmet, “Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation,” Diabetic Medicine, vol. 15, no. 7, pp. 539–553, 1998. View at Publisher · View at Google Scholar · View at Scopus
  32. D. Dabelea, R. A. Bell, R. B. D'Agostino Jr. et al., “Incidence of diabetes in youth in the United States,” Journal of the American Medical Association, vol. 297, no. 24, pp. 2716–2724, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. Hochberg and Y. Benjamini, “More powerful procedures for multiple significance testing,” Statistics in Medicine, vol. 9, no. 7, pp. 811–818, 1990. View at Google Scholar · View at Scopus
  34. H. Baumann and J. Gauldie, “The acute phase response,” Immunology Today, vol. 15, no. 2, pp. 74–80, 1994. View at Publisher · View at Google Scholar · View at Scopus
  35. P. K. Kim and C. S. Deutschman, “Inflammatory responses and mediators,” Surgical Clinics of North America, vol. 80, no. 3, pp. 885–894, 2000. View at Google Scholar · View at Scopus
  36. P. M. Ridker, “Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT),” Journal of Thrombosis and Haemostasis, vol. 7, no. 1, pp. 332–339, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. P. M. Ridker, “Statin therapy for low-LDL, high-hsCRP patients: from JUPITER to CORONA,” Clinical Chemistry, vol. 56, no. 4, pp. 505–507, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Karakas and W. Koenig, “CRP in cardiovascular disease,” Herz, vol. 34, no. 8, pp. 607–613, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. R. J. Glynn, J. G. MacFadyen, and P. M. Ridker, “Tracking of high-sensitivity C-reactive protein after an initially elevated concentration: the JUPITER study,” Clinical Chemistry, vol. 55, no. 2, pp. 305–312, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. H. D. Sesso, J. E. Buring, N. Rifai, G. J. Blake, J. M. Gaziano, and P. M. Ridker, “C-reactive protein and the risk of developing hypertension,” Journal of the American Medical Association, vol. 290, no. 22, pp. 2945–2951, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Hiura, T. Kikuchi, K. Nagasaki, and M. Uchiyama, “Elevation of serum C-reactive protein levels is associated with obesity in boys,” Hypertension Research, vol. 26, no. 7, pp. 541–546, 2003. View at Publisher · View at Google Scholar · View at Scopus